Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Gravitt

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of STD & AIDS|May 15, 2012
Human papillomavirus prevalence, cervical abnormalities and risk factors among female sex workers in Lima, PeruB Brown, M M Blas, A Cabral, et al.
Journal of Clinical Microbiology|January 5, 2000
Improved amplification of genital human papillomavirusesP E Gravitt, C L Peyton, T Q Alessi, et al.
Sexually Transmitted Infections|April 4, 2008
Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, UgandaM Safaeian, M Kiddugavu, P E Gravitt, et al.
The Journal of Infectious Diseases|February 1, 1994
Persistence of type-specific human papillomavirus infection among cytologically normal womenA Hildesheim, M H Schiffman, P E Gravitt, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 22, 2019
The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysisJ C Borgogna, M D Shardell, E K Santori, et al.
Gynecologic Oncology|March 31, 2000
Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervixJ V Lacey, L A Brinton, W A Barnes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 11, 2011
Kinetics of DNA load predict HPV 16 viral clearanceM Marks, P E Gravitt, U Utaipat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reactionP E Gravitt, J V Lacey, L A Brinton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomasJ V Lacey, L A Brinton, F M Abbas, et al.
Cancer Causes & Control : CCC|March 15, 2001
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)J V Lacey, M Frisch, L A Brinton, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of STD & AIDS|May 15, 2012
Human papillomavirus prevalence, cervical abnormalities and risk factors among female sex workers in Lima, PeruB Brown, M M Blas, A Cabral, et al.
Journal of Clinical Microbiology|January 5, 2000
Improved amplification of genital human papillomavirusesP E Gravitt, C L Peyton, T Q Alessi, et al.
Sexually Transmitted Infections|April 4, 2008
Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, UgandaM Safaeian, M Kiddugavu, P E Gravitt, et al.
The Journal of Infectious Diseases|February 1, 1994
Persistence of type-specific human papillomavirus infection among cytologically normal womenA Hildesheim, M H Schiffman, P E Gravitt, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|November 22, 2019
The vaginal metabolome and microbiota of cervical HPV-positive and HPV-negative women: a cross-sectional analysisJ C Borgogna, M D Shardell, E K Santori, et al.
Gynecologic Oncology|March 31, 2000
Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervixJ V Lacey, L A Brinton, W A Barnes, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 11, 2011
Kinetics of DNA load predict HPV 16 viral clearanceM Marks, P E Gravitt, U Utaipat, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2001
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reactionP E Gravitt, J V Lacey, L A Brinton, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomasJ V Lacey, L A Brinton, F M Abbas, et al.
Cancer Causes & Control : CCC|March 15, 2001
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)J V Lacey, M Frisch, L A Brinton, et al.
Pageof 2